| Drug Name: | beta-Carotene (7235-40-7) |
|---|---|
| PubChem ID: | 5280489 |
| SMILES: | CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C=C/C=C(/C=C/C=C(/C=C/C2=C(CCCC2(C)C)C)C)C)/C)/C |
| InchiKey: | OENHQHLEOONYIE-JLTXGRSLSA-N |
| Therapeutic Category: |
| Molecular Weight (dalton) | : | 536.888 |
| LogP | : | 12.6058 |
| Ring Count | : | 0 |
| Hydrogen Bond Acceptor Count | : | 0 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 0 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Endothelium Dysfunction | Thrombomodulin (P07204) | The non-supplemented of the antioxidants selenium and beta-carotene patients experienced increases in von Willebrand factor and soluble thrombomodulin (both p [ ADR Type 5 ] | Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction |
| Endothelium Dysfunction | Von Willebrand factor (P04275) | The non-supplemented of the antioxidants selenium and beta-carotene patients experienced increases in von Willebrand factor and soluble thrombomodulin (both p [ ADR Type 5 ] | Effect of the antioxidants selenium and beta-carotene on HIV-related endothelium dysfunction |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category